[Anti-arrhythmia agents].
D000200:Action Potentials / Q000187:drug effects; D000404:Ajmaline / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D006321:Heart / Q000187:drug effects; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011217:Practolol / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013034:Sparteine / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000188:drug therapy; D014700:Verapamil / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D000404:Ajmaline; D013034:Sparteine; D010672:Phenytoin; D008012:Lidocaine; D014700:Verapamil; D011802:Quinidine; D011342:Procainamide; D011217:Practolol
Antiarrhythmika